SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001047469-07-000510
Filing Date
2007-01-31
Accepted
2007-01-31 14:22:53
Documents
12
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 20-F a2175772z20-f.htm 20-F 3207872
2 EX-1.1 a2175772zex-1_1.htm EX-1.1 38435
3 EX-1.2 a2175772zex-1_2.htm EX-1.2 94405
4 EX-4.5 a2175772zex-4_5.htm EX-4.5 12622
5 EX-4.6 a2175772zex-4_6.htm EX-4.6 392212
6 EX-12.1 a2175772zex-12_1.htm EX-12.1 6450
7 EX-12.2 a2175772zex-12_2.htm EX-12.2 6426
8 EX-13.1 a2175772zex-13_1.htm EX-13.1 3760
9 EX-13.2 a2175772zex-13_2.htm EX-13.2 3712
10 EX-14.1 a2175772zex-14_1.htm EX-14.1 2938
11 G351497.JPG g351497.jpg GRAPHIC 4591
12 G880597.JPG g880597.jpg GRAPHIC 15841
  Complete submission text file 0001047469-07-000510.txt   3798580
Mailing Address LICHSTRASSE 35 BASEL SWITZERLAND CH 4056
Business Address LICHSTRASSE 35 BASEL SWITZERLAND V8 CH 4056
NOVARTIS AG (Filer) CIK: 0001114448 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-15024 | Film No.: 07567581
SIC: 2834 Pharmaceutical Preparations